Respiratory virus season is worsening. Nearly five years since the COVID-19 pandemic took hold, disease experts are urging ...
For immunocompromised individuals, antibody response to RSV vaccines is heterogeneous and about 40% do not seroconvert.
Respiratory syncytial virus (RSV) was first identified as a cause of human infection more than six decades ago, after the virus was isolated from respiratory swabs from two children with outpatient ...